NCT00885027

MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment

Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,342 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: Male
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

This is an exploratory study, to evaluate the improvement in terms of quality of life that can be reached by a group of outpatients with BPH ( Benign Prostatic Hyperplasia ) and nocturia when they are under treatment with Secotex Ocas. This study will explore, the progress in terms of quality of life that can be reached by a group of outpatients with BPH ( Benign Prostatic Hyperplasia) and nocturia treated with Secotex OCAS®. This is a not controlled study, " before and after type", which will consist of an assessment, of the quality of life for outpatients with BPH symptoms including nocturia, through the use of the Spanish version of the Nocturia Quality-of-life (NQoL) questionnaire, at three different moments: 1. Before to start Secotex OCAS® treatment. 2. Thirty (30) days after first visit and starting Secotex OCAS® treatment 3. Ninethy (90) days after first visit and starting Secotex Ocas® treatment

Detailed description

Study Design:

Conditions

• Prostatic Hyperplasia

Timeline

• Start date: 2009-03-01
• Primary completion: 2009-04-01
• First posted: 2009-04-21
• Last updated: 2013-11-14

Locations

18 sites across 1 country: Colombia